T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice
Abstract IL-2Rα, in part, comprises the high affinity receptor for IL-2, a cytokine important in immune proliferation, activation, and regulation. IL-2Rα deficient mice (IL-2Rα-KO) develop systemic autoimmune disease and die from severe anemia between 18 and 80 days of age. These mice develop kineti...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b5b676dfc164f7eb4056f8dcb9d590f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8b5b676dfc164f7eb4056f8dcb9d590f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8b5b676dfc164f7eb4056f8dcb9d590f2021-12-02T13:34:00ZT cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice10.1038/s41598-020-78975-y2045-2322https://doaj.org/article/8b5b676dfc164f7eb4056f8dcb9d590f2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78975-yhttps://doaj.org/toc/2045-2322Abstract IL-2Rα, in part, comprises the high affinity receptor for IL-2, a cytokine important in immune proliferation, activation, and regulation. IL-2Rα deficient mice (IL-2Rα-KO) develop systemic autoimmune disease and die from severe anemia between 18 and 80 days of age. These mice develop kinetically distinct autoimmune progression, with approximately a quarter dying by 21 days of age and half dying after 30 days. This research aims to define immune parameters and cytokine signaling that distinguish cohorts of IL-2Rα-KO mice that develop early- versus late-stage autoimmune disease. To investigate these differences, we evaluated complete blood counts (CBC), antibody binding of RBCs, T cell numbers and activation, hematopoietic progenitor changes, and signaling kinetics, during autoimmune hemolytic anemia (AIHA) and bone marrow failure. We identified several alterations that, when combined, correlate to disease kinetics. Early onset disease correlates with anti-RBC antibodies, lower hematocrit, and reduced IL-7 signaling. CD8 regulatory T cells (Tregs) have enhanced apoptosis in early disease. Further, early and late end stage disease, while largely similar, had several differences suggesting distinct mechanisms drive autoimmune disease kinetics. Therefore, IL-2Rα-KO disease pathology rates, driven by T cell signaling, promote effector T cell activation and expansion and Treg dysfunction.Genevieve N. MullinsKristen M. ValentineMufadhal Al-KuhlaniDan DaviniKirk D. C. JensenKatrina K. HoyerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-16 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Genevieve N. Mullins Kristen M. Valentine Mufadhal Al-Kuhlani Dan Davini Kirk D. C. Jensen Katrina K. Hoyer T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice |
description |
Abstract IL-2Rα, in part, comprises the high affinity receptor for IL-2, a cytokine important in immune proliferation, activation, and regulation. IL-2Rα deficient mice (IL-2Rα-KO) develop systemic autoimmune disease and die from severe anemia between 18 and 80 days of age. These mice develop kinetically distinct autoimmune progression, with approximately a quarter dying by 21 days of age and half dying after 30 days. This research aims to define immune parameters and cytokine signaling that distinguish cohorts of IL-2Rα-KO mice that develop early- versus late-stage autoimmune disease. To investigate these differences, we evaluated complete blood counts (CBC), antibody binding of RBCs, T cell numbers and activation, hematopoietic progenitor changes, and signaling kinetics, during autoimmune hemolytic anemia (AIHA) and bone marrow failure. We identified several alterations that, when combined, correlate to disease kinetics. Early onset disease correlates with anti-RBC antibodies, lower hematocrit, and reduced IL-7 signaling. CD8 regulatory T cells (Tregs) have enhanced apoptosis in early disease. Further, early and late end stage disease, while largely similar, had several differences suggesting distinct mechanisms drive autoimmune disease kinetics. Therefore, IL-2Rα-KO disease pathology rates, driven by T cell signaling, promote effector T cell activation and expansion and Treg dysfunction. |
format |
article |
author |
Genevieve N. Mullins Kristen M. Valentine Mufadhal Al-Kuhlani Dan Davini Kirk D. C. Jensen Katrina K. Hoyer |
author_facet |
Genevieve N. Mullins Kristen M. Valentine Mufadhal Al-Kuhlani Dan Davini Kirk D. C. Jensen Katrina K. Hoyer |
author_sort |
Genevieve N. Mullins |
title |
T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice |
title_short |
T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice |
title_full |
T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice |
title_fullStr |
T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice |
title_full_unstemmed |
T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice |
title_sort |
t cell signaling and treg dysfunction correlate to disease kinetics in il-2rα-ko autoimmune mice |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/8b5b676dfc164f7eb4056f8dcb9d590f |
work_keys_str_mv |
AT genevievenmullins tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice AT kristenmvalentine tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice AT mufadhalalkuhlani tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice AT dandavini tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice AT kirkdcjensen tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice AT katrinakhoyer tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice |
_version_ |
1718392806885556224 |